PL1677808T3 - Łączony preparat do leczenia sepsy - Google Patents

Łączony preparat do leczenia sepsy

Info

Publication number
PL1677808T3
PL1677808T3 PL04790770T PL04790770T PL1677808T3 PL 1677808 T3 PL1677808 T3 PL 1677808T3 PL 04790770 T PL04790770 T PL 04790770T PL 04790770 T PL04790770 T PL 04790770T PL 1677808 T3 PL1677808 T3 PL 1677808T3
Authority
PL
Poland
Prior art keywords
treating sepsis
combined preparation
pharmaceutical composition
active substance
containing active
Prior art date
Application number
PL04790770T
Other languages
English (en)
Inventor
Thomas Stiefel
Original Assignee
Biosyn Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosyn Arzneimittel Gmbh filed Critical Biosyn Arzneimittel Gmbh
Publication of PL1677808T3 publication Critical patent/PL1677808T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
PL04790770T 2003-10-22 2004-10-22 Łączony preparat do leczenia sepsy PL1677808T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10349115A DE10349115A1 (de) 2003-10-22 2003-10-22 Kombinationspräparat zur Behandlung der Sepsis
EP04790770A EP1677808B1 (de) 2003-10-22 2004-10-22 Kombinationspräparat zur behandlung der sepsis
PCT/EP2004/011978 WO2005039603A1 (de) 2003-10-22 2004-10-22 Kombinationspräparat zur behandlung der sepsis

Publications (1)

Publication Number Publication Date
PL1677808T3 true PL1677808T3 (pl) 2011-04-29

Family

ID=34484907

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04790770T PL1677808T3 (pl) 2003-10-22 2004-10-22 Łączony preparat do leczenia sepsy

Country Status (11)

Country Link
US (2) US20080233211A1 (pl)
EP (1) EP1677808B1 (pl)
AT (1) ATE491461T1 (pl)
CA (1) CA2542449C (pl)
DE (2) DE10349115A1 (pl)
DK (1) DK1677808T3 (pl)
ES (1) ES2354798T3 (pl)
PL (1) PL1677808T3 (pl)
PT (1) PT1677808E (pl)
SI (1) SI1677808T1 (pl)
WO (1) WO2005039603A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021216581A1 (en) * 2020-04-20 2021-10-28 Ghoweba Mohamed Samir Elsayed Method of treating and preventing coronavirus disease 19 (covid-19) using a selenium administration

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA754725B (en) * 1974-08-01 1976-06-30 H Stickl Preparation for the treatment of infectious diseases, method for the manufacture thereof, and its use
US4512977A (en) * 1979-10-18 1985-04-23 Lundy Research Laboratories, Inc. Therapeutic selenium compositions and the use thereof
RO80055A2 (ro) * 1980-02-05 1982-10-26 Intreprinderea De Antibiotice,Ro Compozitie medicamentoasa antiacneica,antiseboreica antiactinica si procedeu de obtinere
US4939135A (en) * 1988-10-03 1990-07-03 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5110722A (en) * 1989-11-09 1992-05-05 Cryolife, Inc. Cell, tissue or organ storage solution
JPH08308561A (ja) * 1995-05-16 1996-11-26 Sumitomo Electric Ind Ltd 動物細胞培養用無血清培地
WO1998047497A2 (en) * 1997-04-23 1998-10-29 Fleming & Company, Pharmaceuticals Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
FR2782642B1 (fr) * 1998-08-31 2001-12-07 Xavier Forceville Utilisation du selenium pour le traitement de patients atteints d'un syndrome de reponse inflammatoire systemique (sirs), et composition pour la mise en oeuvre du traitement
KR100371274B1 (ko) * 2000-08-09 2003-02-06 정상훈 모발 이식용 키트
AT412703B (de) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung

Also Published As

Publication number Publication date
US20080233211A1 (en) 2008-09-25
SI1677808T1 (sl) 2011-04-29
PT1677808E (pt) 2010-12-28
DK1677808T3 (da) 2011-03-28
CA2542449C (en) 2011-05-31
CA2542449A1 (en) 2005-05-06
DE10349115A1 (de) 2005-06-16
DE502004012009D1 (de) 2011-01-27
ATE491461T1 (de) 2011-01-15
ES2354798T3 (es) 2011-03-18
EP1677808A1 (de) 2006-07-12
US20110293748A1 (en) 2011-12-01
EP1677808B1 (de) 2010-12-15
WO2005039603A1 (de) 2005-05-06

Similar Documents

Publication Publication Date Title
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
MY143795A (en) Tetrahydropyridoindole derivatives
GEP20125565B (en) Lactam compounds and their pharmaceutical use
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
EA200602137A1 (ru) Гидрогелевые препараты интерферона
TW200510375A (en) New compounds
TNSN03116A1 (en) Pulmonary administration of chemically modified insulin
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
TW200727903A (en) Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate
MY149601A (en) Masking the taste of powders
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
IL173369A (en) Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
HK1119596A1 (en) Use of yrazolopyrimidinone derivative in the preparation of agent for the prevention and treatment of liver diseases
IL151628A0 (en) Combination therapies with vascular damaging activity
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
WO2002015933A3 (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
PL1677808T3 (pl) Łączony preparat do leczenia sepsy
SE0000303D0 (sv) Novel compounds
EP1603595A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRUG INDEPENDENCE
SE0203817D0 (sv) New composition
WO2003043632A3 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
DK1200088T3 (da) Sammensætning indeholdende paracetamol og drotaverin